Matches in SemOpenAlex for { <https://semopenalex.org/work/W2270661844> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W2270661844 endingPage "1090" @default.
- W2270661844 startingPage "1089" @default.
- W2270661844 abstract "In their Heart paper, Hassell et al 1 present an original analysis of four studies comparing single and dual antiplatelet therapy after transcatheter aortic valve implantation (TAVI). There was no difference in the primary endpoint of net adverse clinical and cerebral events combining 30-day rates of mortality, acute coronary syndrome, stroke and major bleeding. However, there was a strong trend, although not statistically significant, towards less major or life-threatening bleeding at 30 days in patients receiving aspirin alone as compared with those treated using the usual combination of aspirin and clopidogrel early after TAVI. These findings challenge current recommendations and may contribute to improving patient outcome after TAVI.Guidelines consistently recommend dual antiplatelet therapy during 3–6 months after TAVI followed by single antiplatelet therapy (table 1).2–5 This relies mainly on the extrapolation of antithrombotic regimens following coronary stenting. However, despite the common presence of a metallic stent, coronary stenting and TAVI differ by a number of features which may influence thrombus formation, in particular vessel diameter, environment (atheromatous plaques or calcified aortic leaflets), presence of prosthetic leaflets and the frequency of associated atrial fibrillation.View this table:Table 1 Current recommendations for antithrombotic therapy after transcatheter aortic valve implantation (TAVI) or surgical bioprosthetic valve replacementRecommended antithrombotic regimens markedly differ between TAVI and surgical aortic valve replacement (AVR) using a bioprosthesis. Anticoagulant therapy was initially recommended during the first 3 months following bioprosthetic AVR, which corresponds to the time delay for endothelialisation of the sewing ring. However, this rationale was challenged by series suggesting that antiplatelet therapy alone may have a better risk:benefit profile.2 This led to changes in ESC/EACTS and American Heart Association/American …" @default.
- W2270661844 created "2016-06-24" @default.
- W2270661844 creator A5021922273 @default.
- W2270661844 date "2015-05-07" @default.
- W2270661844 modified "2023-09-30" @default.
- W2270661844 title "Antithrombotic therapy after transcatheter aortic valve implantation: Table 1" @default.
- W2270661844 cites W1948348644 @default.
- W2270661844 cites W2037447718 @default.
- W2270661844 cites W2052522943 @default.
- W2270661844 cites W2067905792 @default.
- W2270661844 cites W2100876297 @default.
- W2270661844 cites W2142521193 @default.
- W2270661844 cites W2156613835 @default.
- W2270661844 cites W2168701277 @default.
- W2270661844 cites W2396319370 @default.
- W2270661844 cites W2884532285 @default.
- W2270661844 cites W6668650 @default.
- W2270661844 doi "https://doi.org/10.1136/heartjnl-2015-307762" @default.
- W2270661844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25953968" @default.
- W2270661844 hasPublicationYear "2015" @default.
- W2270661844 type Work @default.
- W2270661844 sameAs 2270661844 @default.
- W2270661844 citedByCount "0" @default.
- W2270661844 crossrefType "journal-article" @default.
- W2270661844 hasAuthorship W2270661844A5021922273 @default.
- W2270661844 hasConcept C126322002 @default.
- W2270661844 hasConcept C141071460 @default.
- W2270661844 hasConcept C164705383 @default.
- W2270661844 hasConcept C2777015399 @default.
- W2270661844 hasConcept C2780714102 @default.
- W2270661844 hasConcept C2909817843 @default.
- W2270661844 hasConcept C71924100 @default.
- W2270661844 hasConceptScore W2270661844C126322002 @default.
- W2270661844 hasConceptScore W2270661844C141071460 @default.
- W2270661844 hasConceptScore W2270661844C164705383 @default.
- W2270661844 hasConceptScore W2270661844C2777015399 @default.
- W2270661844 hasConceptScore W2270661844C2780714102 @default.
- W2270661844 hasConceptScore W2270661844C2909817843 @default.
- W2270661844 hasConceptScore W2270661844C71924100 @default.
- W2270661844 hasIssue "14" @default.
- W2270661844 hasLocation W22706618441 @default.
- W2270661844 hasLocation W22706618442 @default.
- W2270661844 hasOpenAccess W2270661844 @default.
- W2270661844 hasPrimaryLocation W22706618441 @default.
- W2270661844 hasRelatedWork W1513522610 @default.
- W2270661844 hasRelatedWork W2121864743 @default.
- W2270661844 hasRelatedWork W2517015656 @default.
- W2270661844 hasRelatedWork W2517354513 @default.
- W2270661844 hasRelatedWork W2599306953 @default.
- W2270661844 hasRelatedWork W2615510955 @default.
- W2270661844 hasRelatedWork W2888369259 @default.
- W2270661844 hasRelatedWork W2900348376 @default.
- W2270661844 hasRelatedWork W3094206399 @default.
- W2270661844 hasRelatedWork W3187784331 @default.
- W2270661844 hasVolume "101" @default.
- W2270661844 isParatext "false" @default.
- W2270661844 isRetracted "false" @default.
- W2270661844 magId "2270661844" @default.
- W2270661844 workType "article" @default.